Experiment: 7JMY

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM 2-mercapto ethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 600
2	1D T1	0.5 mM [U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM 2-mercapto ethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 600
3	1D T2	0.5 mM [U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM 2-mercapto ethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 600
4	2D HNOE	0.5 mM [U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM 2-mercapto ethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 600
5	2D 1H-15N HSQC	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
14	2D 1H-13C HSQC aliphatic	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
13	3D HNCO	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
12	3D HNCA	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
11	3D HNCACB	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
10	3D CBCA(CO)NH	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
9	3D HBHA(CO)NH	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
8	3D HCCH-TOCSY	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
7	3D 1H-13C,15N simNOESY	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800
6	3D 1H-13C NOESY aromatic	0.5 mM [U-13C; U-15N] Brd3 ET Domain, 100 mM sodium chloride, 20 mM Na3PO4, 2 mM beta-mercaptoethanol	90% H2O/10% D2O	100mM NaCl mM	7.0	1 atm	298	Bruker AVANCE 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing	The structures are based on a total of 1277 conformationally-restricting NOE-derived distance constraints, 122 dihedral angle constraints, and 38 hydrogen bond constraints (16.3 constraints per residue excluding tags; 1.8 long range constraints per residue). Structure determination was performed iteratively using CYANA and ASDP (Cyana). The 20 lowest energy structures were further refined by restrained molecular dyanmics/energy minimization in explicit water (CNS).	CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (target function)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger A. T. et.al.
2	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	AutoAssign	2.4	Zimmerman, Moseley, Kulikowski and Montelione
5	geometry optimization	ASDP	1.2	Huang et al
4	peak picking	Sparky		Goddard
6	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
7	collection	TopSpin	2.3b	Bruker Biospin

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.